June 22, 2018
Joint Commission seeking comments on anticoagulation NPSG
Editor's Note
The Joint Commission announced on June 20 that it is seeking comments on proposed changes to the National Patient Safety Goal (NPSG) 03.05.01 on reducing harm from anticoagulant therapy.
Revised requirements, which will address the use of new direct oral anticoagulant medications, include:
- drug selection
- dosing and monitoring
- bleeding reversal
- perioperative management
- adverse drug events.
Comments will be accepted through July 31, 2018.
Free Daily News
- Study: Longer shifts, understaffing increase nurse sickness absence
- Power loss risks prompt FDA Class 1 recall designation for heart pump accessories
- Therapy dogs ease nurse burnout, boost morale
- Personalized perioperative pain management reduces opioid use
- Study: Colibactin-producing gut bacteria fuel colorectal cancer surge
- Augmented reality gains FDA nod, 10k-case milestone in orthopedics, strides in outpatient surgery
- Smart patient selection anchors DISC’s high-acuity spine ASC model
- Postop opioid prescriptions following outpatient surgery see steep, sustained fall
- Study: Bariatric surgery offers cost, survival benefits for cirrhosis patients
- AI monitoring, remote surgery advance
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement